中药复方治疗心脏神经官能症疗效Meta分析及用药规律分析
作者:
作者单位:

(1. 陕西中医药大学,陕西省中西医结合心血管病防治重点实验室,咸阳市中西医结合心血管病防治重点实验室,陕西 西安 712046;2. 陕西中医药大学真实世界临床研究院,陕西 西安 712046;3. 陕西省人民医院中心实验室,陕西 西安 710068;4. 陕西中医药大学第二附属医院心内科,陕西 西安 712000)

作者简介:

通讯作者:

中图分类号:

R277.7;R259

基金项目:

收稿日期: 2020 - 01- 28
基金项目: 国家自然科学基金面上项目(81573823);陕西省中医药管理局项目(2019-WT003)
第一作者简介: 曹语(1995-),女,在读硕士研究生,研究方向:中西医结合心血管病防治。
△通信作者: 王海芳,E-mail: wanghaifang03@126.com
3. Central Laboratory, Shaanxi Provincial People’s Hospital, Xi’an 710068,China; 4. Department of Cardiology, the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xi’an 712000, China)


Meta-analysis and Medication Analysis of the Oral Chinese Herbal Compoundin the Treatment of Cardiac Neurosis
Author:
Affiliation:

(1. Shaanxi Key Laboratory of Integrated Traditional and Western Medicine for Prevention and Treatment of Cardiovascular Diseases,Xianyang Key Laboratory of Integrated Traditional and Western Medicine for Prevention and Treatment of Cardiovascular Diseases, Shaanxi University of Traditional Chinese Medicine, Xi’an 712046, China;2. Real World Clinical Research Institute, Shaanxi University of Traditional Chinese Medicine, Xi’an 712046,China;

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的系统评价口服中药复方治疗心脏神经官能症的有效性和安全性,并探究其用药规律。方法 通过中英文文献检索系统全面检索中药复方治疗心脏神经官能症的临床试验资料,检索时限均为建库至2019年12月。对严格筛选、提取后的文献根据Cochrane系统评价方法评估质量,并利用Revman5.3 软件完成数据分析。结果 最终纳入20个研究,共计1 778名患者。Meta分析结果显示,中药复方的临床疗效优于西药组[OR=3.89, 95%CI (2.93,5.18),P<0.000 01];中药复方在改善中医证候积分方面优于西药组[SMD=-1.04,95%CI (-1.39,-0.70),P<0.000 01];口服中药复方改善负性心理情绪优于西药组,焦虑自评量表(SAS)前后评分[MD=-5.61,95%CI (-6.68,-4.54),P<0.000 01],抑郁自评量表(SDS)前后评分[MD=-5.87,95%CI(-7.00,-4.73),P<0.000 01];对试验组与对照进行安全性分析,结果显示[OR=0.34,95%CI(0.14,0.84),P=0.02];所用中药复方单味药以茯苓使用频次最高,药味归类以白芍为主的补益药使用频次最高。结论 相比西药治疗,口服中药复方对心脏神经官能症具有更好的综合疗效,且用药多以补益类、安神类中药为主。

    Abstract:

    Objective To systematically evaluate the efficacy and safety of the oral Chinese herbal compound in the treatment of cardiac neurosis and to analyze the regularity of its medication rules. Methods The clinical trial data on the treatment of cardiac neurosis by Chinese herbal compounds were comprehensively searched by literature retrieval system, the search time is from database creation to December 2019. Two researchers screened and extracted data independently,the cochrane systematic was used to assess the quality of the literature. Finally, the RevMan 5.3 software was employed for Meta-analysis. Results A total of 1 778 patients were included in 20 clinical studies.Meta-analysis showed that the clinical effect of oral Chinese herbal compound is better than that of western medicine[OR=3.89, 95%CI(2.93, 5.18), P<0.000 01]. Chinese herbal compound is better than western medicine in improving TCM symptom score[SMD= -1.04, 95%CI (-1.39, -0.70), P<0.000 01]. Chinese herbal compound is better than western medicine in improving negative psychological mood, the SAS score before and after treatment[MD= -5.61, 95%CI(-6.68, -4.54), P<0.000 01], the SDS score before and after treatment[MD= -5.87, 95%CI(-7.00, -4.73), P<0.000 01]. Meta-analysis of the safety of the Chinese herbal compound treatment showed[OR= 0.34, 95%CI (0.14, 0.84), P=0.02]. Among the Chinese herbal compound used, poria cocos is the most frequently used single herb,and radix paeoniae alba is the most frequently used tonic herb. Conclusion Compared with western medicine alone, oral Chinese herbal compound has a better comprehensive effect on cardiac neurosis, and no significant adverse reaction. And it is mainly used as tonic or tranquilizer.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭